scholarly journals The Influences of Prescribed Diets on Serum Lipid Levels in Patients with Diabetes Mellitus

1987 ◽  
Vol 14 (6) ◽  
pp. 1299-1304
Author(s):  
Noboru SAITO ◽  
Fusae OHTSUJI ◽  
Kimiko MATSUSHITA
Keyword(s):  
Diabetes Mellitus ◽  
Serum Lipid ◽  
Lipid Levels ◽  
Serum Lipid Levels ◽  
Patients With Diabetes

scholarly journals Effect of Temocapril Hydrochloride on Serum Lipid Levels in Patients with Hypertensive Type 2 Diabetes Mellitus

2001 ◽  
Vol 8 (1) ◽  
pp. 25-29 ◽  
Author(s):  
Yoh Miyashita ◽  
Yoshiaki Ito ◽  
Shoichiro Hasiguchi ◽  
Mitsuya Totsuka ◽  
Akiko Aoki ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Serum Lipid ◽  
Lipid Levels ◽  
Serum Lipid Levels

Quantitative Measurement of Hard Exudates in Patients With Diabetes and Their Associations With Serum Lipid Levels

2013 ◽  
Vol 54 (8) ◽  
pp. 5544 ◽  
Author(s):  
Mariko Sasaki ◽  
Ryo Kawasaki ◽  
Jonathan E. Noonan ◽  
Tien Yin Wong ◽  
Ecosse Lamoureux ◽  
...  
Keyword(s):  
Serum Lipid ◽  
Quantitative Measurement ◽  
Lipid Levels ◽  
Hard Exudates ◽  
Serum Lipid Levels ◽  
Patients With Diabetes

scholarly journals Therapeutic Effects of Fenofibrate on Blood Serum Lipid in Type II Diabetic Patients in El-beida, Libya

2019 ◽  
Vol 34 (3) ◽  
pp. 146-152
Author(s):  
Yahya Saber E. Mansour ◽  
Nusieba A. Mohammed Ibrahim
Keyword(s):  
Diabetes Mellitus ◽  
Blood Serum ◽  
Type Ii Diabetes ◽  
Serum Lipid ◽  
Total Sterol ◽  
Type Ii Diabetes Mellitus ◽  
Diabetic Patients ◽  
Type Ii ◽  
Lipid Levels ◽  
Serum Lipid Levels

The risks of dyslipidemia and cardiovascular diseases are well known to be increased in diabetic patients. Moreover, the therapeutic response of fenofibrate drug on blood serum lipid is also known. However, previous studies did not compare the outcomes of fenofibrate on blood serum levels in patients with type II diabetes mellitus with non-diabetic patients. The purpose of this study was to analyze the outcomes of fenofibrate on blood serum lipid profiles in hyperlipidemic patients with type II diabetes mellitus compared to hyperlipidemic patients without diabetes mellitus. This study was conducted on 40 type II diabetic patients and 30 non-diabetic patients. Their ages varied 30-55 years and all of them were hyperlipidemic. Blood serum lipid levels were measured before and once treatment at 1, 2, and 4 months. It was found that the levels of S. Total sterol and S. LDL-C were less in diabetic patients than in non-diabetic patients once they were exploited the different doses of fenofibrate, whereas the changes in S. HDL-C and S. triglyceride were nearly similar in each. Furthermore, it was noticed that just about the same responses of S. Total sterol and S. LDL-C reduction were achieved in diabetic patients once they were using a higher dose than that used for non-diabetic patients. Thus, higher doses of fenofibrate are required to reduce blood serum lipid levels in diabetic patients as compared to non-diabetic patients.

Sign in / Sign up

Export Citation Format

Share Document